BVI announces launch of SERENITY and SERENITY Toric IOLs at ESCRS

BVI announced the new IOLs will launch at this year's ESCRS Congress. Image credit: ©VRVIRUS – stock.adobe.com

BVI, a global ophthalmic device company, announced its SERENITY and SERENITY Toric premium monofocal IOLs will launch at the European Society of Cataract and Refractive Surgery (ESCRS) meeting in Barcelona, Spain. The congress will take place from 6 to 10 September, 2024.

The SERENITY and SERENITY Toric IOLs are non-diffractive, aspheric IOLs, and are the second generation of BVI’s pioneering ISOPURE family, which was first introduced in 2019. According to the company, these lenses provide far vision equal to a monofocal but with good intermediate vision up to 66 cm.

Furthermore, the double C-loop POD platform, exclusive to BVI, allows the IOL to be rotated clockwise or counterclockwise to align the cylinder with the axis. For patients with astigmatism, the POD platform allows for a toric IOL that remains stable in the capsular bag.1

“As we launch the second-generation SERENITY and SERENITY Toric IOLs, BVI views this IOL as potentially a game-changer when it comes to standard of care for monofocal procedures,” said Shervin Korangy, President and CEO of BVI. “Our portfolio includes a wide range of IOLs, meticulously designed from material to haptics to optics to provide the optimal outcome without the burden of retro-fitting legacy predicate devices.”

According to the news release from BVI, the SERENITY and SERENITY Toric will have full commercial availability in CE-accepting markets in 2025.¹

Reference

1. BVI to Launch New SERENITY and SERENITY Toric Premium Monofocal IOLs. Press Release; September 3, 2024. Accessed September 3, 2024. https://www.bvimedical.com/us/bvi-to-launch-new-serenity-and-serenity-toric-premium-monofocal-iols/